美国 · SEC FORM 4
RECURSION PHARMACEUTICALS, INC.
RXRX · Nasdaq · CIK 0001601830 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
41 同一窗口内观察到的 Form 4 交易行
15 sales · 26 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2023-03-02 · Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC · $522.5K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Gibson ChristopherDirector
○▼○○▼○○▼○▼
Borgeson BlakeDirector
▼▼○▼▼▼▼
Taylor Ben RChief Financial Officer
○○○○
Khan NajatCEO and President
○▼○▼
Bumpus NamandjeDirector
▼○▼
Li Dean YDirector
○○○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-03-02 · Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC.
近期 Form 4 活动
0买入
36卖出
69其他 Form 4 交易行
71SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出15 sale line(s) · 仅供背景
其他26 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 157,938,412
- 上期报告
- 178,724,433
- 日均成交量
- 25,774,840
- 回补天数
- 6.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-03-02 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 66,822 | USD 7.82 | USD 522,548 | SEC 申报 ↗ |
| 2023-03-01 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 48,867 | USD 7.94 | USD 388,004 | SEC 申报 ↗ |
| 2023-02-28 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 815 | USD 7.97 | USD 6,496 | SEC 申报 ↗ |
| 2023-02-27 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 52,500 | USD 7.69 | USD 403,725 | SEC 申报 ↗ |
| 2023-02-24 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 109,118 | USD 7.64 | USD 833,662 | SEC 申报 ↗ |
| 2023-02-23 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 51,864 | USD 7.79 | USD 404,021 | SEC 申报 ↗ |
| 2023-02-22 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 50,941 | USD 7.83 | USD 398,868 | SEC 申报 ↗ |
| 2023-02-21 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 94,418 | USD 7.74 | USD 730,795 | SEC 申报 ↗ |
| 2023-02-17 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 63,382 | USD 7.71 | USD 488,675 | SEC 申报 ↗ |
| 2023-02-16 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 42,682 | USD 7.90 | USD 337,188 | SEC 申报 ↗ |
| 2023-02-14 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 6,300 | USD 7.95 | USD 50,085 | SEC 申报 ↗ |
| 2023-02-13 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 32,474 | USD 7.97 | USD 258,818 | SEC 申报 ↗ |
| 2023-02-10 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 11,000 | USD 7.98 | USD 87,780 | SEC 申报 ↗ |
| 2023-02-01 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 600 | USD 7.97 | USD 4,782 | SEC 申报 ↗ |
| 2023-01-26 | Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC | 买入 (P) | Class A Common Stock | 7,886 | USD 7.99 | USD 63,009 | SEC 申报 ↗ |
Form 4 申报证据
105 transaction lines in the latest 365-day window; 1,125 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | HERSHBERG ROBERT | 卖出 (S) | Class A Common Stock | 25,000 | USD 5.00 | USD 125,000 | SEC 申报 ↗ |
| 2026-10-06 | HERSHBERG ROBERT | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 2.22 | USD 55,500 | SEC 申报 ↗ |
| 2026-10-06 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 50,000 | USD 4.84 | USD 242,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | HERSHBERG ROBERT | 卖出 (S) | Class A Common Stock | 25,000 | USD 5.00 | USD 125,000 | SEC 申报 ↗ |
| 2026-10-06 | HERSHBERG ROBERT | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 2.22 | USD 55,500 | SEC 申报 ↗ |
| 2026-10-06 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 50,000 | USD 4.84 | USD 242,000 | SEC 申报 ↗ |
| 2026-10-01 | Li Dean Y | 奖励／授予 (A) | Class A Common Stock | 3,378 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Dar Zavain | 奖励／授予 (A) | Class A Common Stock | 4,607 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-15 | Taylor Ben R | 代扣税 (F) | Class A Common Stock | 5,396 | USD 3.41 | USD 18,400 | SEC 申报 ↗ |
| 2026-09-08 | Khan Najat | 卖出 (S) | Class A Common Stock | 22,408 | USD 3.52 | USD 78,876 | SEC 申报 ↗ |
| 2026-09-01 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 30,000 | USD 3.34 | USD 100,200 | SEC 申报 ↗ |
| 2026-08-17 | Taylor Ben R | 代扣税 (F) | Class A Common Stock | 25,018 | USD 3.16 | USD 79,057 | SEC 申报 ↗ |
| 2026-08-17 | Khan Najat | 代扣税 (F) | Class A Common Stock | 80,498 | USD 3.16 | USD 254,374 | SEC 申报 ↗ |
| 2026-08-17 | Hallett David | 代扣税 (F) | Class A Common Stock | 26,657 | USD 3.16 | USD 84,236 | SEC 申报 ↗ |
| 2026-08-04 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 30,000 | USD 3.25 | USD 97,500 | SEC 申报 ↗ |
| 2026-07-07 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 40,000 | USD 3.96 | USD 158,400 | SEC 申报 ↗ |
| 2026-07-01 | Li Dean Y | 奖励／授予 (A) | Class A Common Stock | 3,747 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Dar Zavain | 奖励／授予 (A) | Class A Common Stock | 5,109 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Bumpus Namandje | 卖出 (S) | Class A Common Stock | 3,963 | USD 3.18 | USD 12,602 | SEC 申报 ↗ |
| 2026-06-17 | Sun Elaine D | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Michor Franziska | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Li Dean Y | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | HERSHBERG ROBERT | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Dar Zavain | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Bumpus Namandje | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Borgeson Blake | 奖励／授予 (A) | Class A Common Stock | 88,424 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Taylor Ben R | 代扣税 (F) | Class A Common Stock | 5,396 | USD 3.15 | USD 16,997 | SEC 申报 ↗ |
| 2026-06-05 | Khan Najat | 卖出 (S) | Class A Common Stock | 23,588 | USD 3.58 | USD 84,445 | SEC 申报 ↗ |
| 2026-06-05 | Gibson Christopher | 卖出 (S) | Class A Common Stock | 40,000 | USD 3.62 | USD 144,800 | SEC 申报 ↗ |
| 2026-06-05 | Gibson Christopher | C (C) | Class A Common Stock | 40,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Bumpus Namandje | 卖出 (S) | Class A Common Stock | 4,386 | USD 3.54 | USD 15,526 | SEC 申报 ↗ |
| 2026-06-02 | Borgeson Blake | 卖出 (S) | Class A Common Stock | 30,000 | USD 3.68 | USD 110,400 | SEC 申报 ↗ |
| 2026-05-22 | Gibson Christopher | 卖出 (S) | Class A Common Stock | 40,000 | USD 3.08 | USD 123,200 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RXRX |
| CIK | 0001601830 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 1,125 transaction lines from 2021-04-16 to 2026-10-06 29 P purchase lines · 410 S sale lines · 686 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.